Cc1c[nH]c(CN(C)Cc2c(C(=O)N3CCCCCCC3)nc3ccc(Cl)cn23)n1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?